Overseas registration of Mainland Individuals control
Walkers Corporate Limited, 190 Elgin Avenue, George Town,Grand Cayman KY1-9008, Cayman Islands
Head Office and Principal Place of Business
40 / F, Dah Sing Financial Centre, 248 Queen's Road East, Wanchai, Hong Kong
Hong Kong motherboard
Jiakos Pharmaceutical Group Co., Ltd. is a Chinese investment holding company mainly engaged in clinical drug research and development. The company is mainly responsible for the independent discovery and development of innovative tumor therapy. The company's main drug development projects include JAB-3068 and allosteric SHP2 inhibitors in the clinical phase of JAB-3312. The company mainly does business in the domestic market.
Jiakos Pharmaceutical Group Co., Ltd. is committed to providing breakthrough treatment solutions for patients, and the company's vision is to work with partners to become a globally recognized leader in drug research and development. The company's laboratories are located in Beijing, China and Massachusetts, USA, and the experimental platform has allosteric inhibitors for the development of protein phosphatase, KRAS and other transcription factors. Garkos has received investment from several biotechnology investment institutions, including QiMing Venture Partners, Lilly Asia Fund, Hillhouse and Taiwan Yusheng.